4//SEC Filing
Hughes Eric A 4
Accession 0000950170-25-102977
CIK 0000818686other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:02 PM ET
Size
9.5 KB
Accession
0000950170-25-102977
Insider Transaction Report
Form 4
Hughes Eric A
See "Remarks"
Transactions
- Sale
Ordinary Shares
2025-08-01$15.16/sh−52,742$799,437→ 0 total - Exercise/Conversion
Ordinary Shares
2025-08-01+52,742→ 52,742 total - Exercise/Conversion
Restricted Share Units
2025-08-01−52,742→ 52,744 total→ Ordinary Shares (52,742 underlying)
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.13 to $15.31, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Restricted share units were granted on August 1, 2022, with 52,742 vested on each of August 1, 2023, August 1, 2024 and August 1, 2025, and 52,744 vesting on August 1, 2026.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001938678
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 4:02 PM ET
- Size
- 9.5 KB